188260 — Sanigen Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩21bn
- KR₩15bn
- KR₩22bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | — | — | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 20,262 | 23,487 | 25,221 | 26,758 | 22,268 |
Cost of Revenue | |||||
Gross Profit | 3,123 | 3,525 | 3,615 | 3,896 | 3,039 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 21,110 | 25,542 | 28,088 | 30,837 | 28,585 |
Operating Profit | -848 | -2,055 | -2,867 | -4,079 | -6,316 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3,145 | -2,593 | -4,281 | -4,065 | -8,833 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3,145 | -2,593 | -4,281 | -4,065 | -8,775 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -3,142 | -2,595 | -4,281 | -4,065 | -8,775 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3,142 | -2,595 | -4,281 | -4,065 | -8,775 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -470 | -425 | -641 | -607 | -1,722 |
Dividends per Share |